文章基本信息

标题：Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
本地全文：下载
作者：Maya Imbrechts ; Wim Maes ; Louanne Ampofo 等
期刊名称：iScience
印刷版ISSN：2589-0042
出版年度：2022
卷号：25
期号：8
页码：1-25
DOI：10.1016/j.isci.2022.104705
语种：English
出版社：Elsevier
摘要：SummaryTreatment with neutralizing monoclonal antibodies (mAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributes to COVID-19 management. Unfortunately, SARS-CoV-2 variants escape several of these recently approved mAbs, highlighting the need for additional discovery and development. In a convalescent patient with COVID-19, we identified six mAbs, classified in four epitope groups, that potently neutralized SARS-CoV-2 D614G, beta, gamma, and delta infectionin vitro, with three mAbs neutralizing omicron as well. In hamsters, mAbs 3E6 and 3B8 potently cured infection with SARS-CoV-2 Wuhan, beta, and delta when administered post-viral infection at 5 mg/kg. Even at 0.2 mg/kg, 3B8 still reduced viral titers. Intramuscular delivery of DNA-encoded 3B8 resulted inin vivomAb production of median serum levels up to 90 μg/mL, and protected hamsters against delta infection. Overall, our data mark 3B8 as a promising candidate against COVID-19, and highlight advances in both the identification and gene-based delivery of potent human mAbs.Graphical abstractDisplay OmittedHighlights•Discovery of potent neutralizing antibodies classified in different epitope groups•Antibodies neutralize SARS-CoV-2 D614G, beta, gamma, delta, and omicronin vitro•Selected antibodies potently treat SARS-CoV-2 infection in hamsters at low doses•Intramuscular delivery of DNA-encoded 3B8 protects hamsters against infectionImmunology; Virology.